Caricamento azienda
Just reported
Q3 2026 results
From UFP Technologies's results release of 3 novembre 2026; its quarterly report has since been filed.
Revenue
Actual
172,4M USD
+12% y/y
-0,9% q/qGuided
—
No guide given
EPS, GAAP
Actual
2,64 USD
+25% y/y
-1,5% q/qGuided
—
No guide given
EPS, adjusted: 2,64 USD
Operating income, GAAP
Actual
27,6M USD
+18% y/y
-1,8% q/qGuided
—
No guide given
Operating income, adjusted: 30,1M USD
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes UFP Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Devices
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc131,6B USDA+
SYKStryker Corp.117,9B USDA+
EWEdwards Lifesciences Corporation61,6B USDA+
GEHCGE Healthcare Technologies Inc.37,5B USDA
GKOSGlaukos Corp14,5B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 ott 2026CBGraded C, now B
MCKMckesson Corporation4 nov 2026BAGraded B, now A
CVSCVS Health Corp4 nov 2026BAGraded B, now A- EWEdwards Lifesciences Corporation4 nov 2026BAGraded B, now A
- GEHCGE Healthcare Technologies Inc.28 ott 2026CAGraded C, now A
Costruito dai documenti depositati da UFP Technologies, Inc. presso la Securities and Exchange Commission (SEC), l’autorità di vigilanza statunitense. Le cifre sono quelle dichiarate, con lo storico per azione ricalcolato sulla base azionaria di oggi. Questo descrive un’azienda: non è consulenza finanziaria né una raccomandazione di acquisto o vendita.
